generate PDF ... 
Corporate Profile
Overview
vasopharm is a pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases and their consequences – indications with significant unmet clinical need. The company is focused on the development of therapeutics which steer the availability of biological nitric oxide (NO) over the entire NO signal cascade and its functional counterpart the NAD(P)H oxidase (NOX) family.
Business Model
vasopharm focuses on drug development in acute niche indications with an unmet medical need which enables the company to rapidly demonstrate clinical efficacy. In addition to developing its own products to demonstrate clinical efficacy, vasopharm is actively seeking complementary opportunities in the area of acute cardiovascular or CNS diseases preferably in late pre-clinical or early clinical state of development.
